People: Bausch Health Companies Inc (BHC.TO)
Dr. Argeris (Jerry) N. Karabelas, Ph.D., is Independent Director of the Company. He has served on the Board since June 2016. Since December 2001, Dr. Karabelas has been a Partner at Care Capital, LLC (“Care Capital”), a life sciences venture firm with $500M under management. Prior to his work at Care Capital, Dr. Karabelas was the founder and Chairman at Novartis BioVenture Fund, and served as Head of Healthcare and CEO of Worldwide Pharmaceuticals for Novartis Pharma AG. Prior to joining Novartis, Dr. Karabelas was Executive Vice President of SmithKline Beecham, where he was responsible for U.S. and European operations, regulatory and strategic marketing. Dr. Karabelas has been a director of REGENEXBIO Inc., a clinical-stage biotechnology company, since May 2015. He has also served on the board of Braeburn Pharmaceuticals, Inc., a private specialty pharmaceuticals company, since 2015, and has been the Chairman of Polyphor, LTD., a privately-held biopharmaceutical company, since June 2013. Dr. Karabelas previously served from June 2012 to June 2016 as Chairman of Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company (which merged with Rocket Pharmaceuticals, Inc. in 2017), and from 2003 to 2013 as Chairman of Vanda Pharmaceuticals, a global biopharmaceutical company.
|Total Annual Compensation, USD||135,622|
|Restricted Stock Award, USD||250,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||--|
|Fiscal Year Total, USD||385,622|